Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

PCRX — Pacira BioSciences, Inc. Dilution Risk Tracker

Track PCRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PCRX — Get alerts when the score changes →

As of October 13, 2026, Pacira BioSciences, Inc. (PCRX) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Pacira BioSciences, Inc. has a market capitalization of $1.45B, 39.86M shares outstanding, 243 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰Cash Runway—
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PCRX.
🔔 Track PCRX — Get forecast alerts →

Market Data

Market Cap$1.45B
Shares Outstanding39.86M
Float33.67M
Cash$251.03M
Debt$363.12M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore24/100DilutionWatch score record
Shares Outstanding39.86MVerified float table or market cache
Public Float33.67MVerified float table or market cache
Market Cap$1.45BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.4% shares (2026Q1 vs prior)
243 institutional holders · 51.63M shares
#1 BlackRock, Inc. 6.74M shares
#2 MORGAN STANLEY 3.73M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.57M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.08M
Days to Cover15.1
% of Float24.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PCRX Dilution Snapshot

Pacira BioSciences, Inc. (PCRX) has a DilutionScore of 24/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PCRX's DilutionScore is currently 24/100 (Low risk), with 1 score change tracked over 89 days. The score improved from 20/100 (Low risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202624/100LOW60 days
Jul 16 – Aug 13, 202620/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PCRX shares outstanding have decreased 2.8% from 40.49M (Mar 2026) to 39.35M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202639.35M33.67M▼ 7.48%
May 08, 202639.35M36.39M▼ 0.23%
May 02, 202639.32M36.47M▼ 2.82%
Apr 26, 202640.49M37.53M▼ 0.28%
Mar 14, 202640.49M37.64M▲ 7.99%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PCRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PCRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PCRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for PCRX
PCRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.